DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tauopathy
Tauopathy
Pathologic Thr175 Tau Phosphorylation in CTE and CTE with ALS
Immune Effector Mechanisms and Designer Vaccines Stewart Sell Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY, USA
Investigation of Anti-Iglon5-Induced Neurodegenerative Changes in Human Neurons
An Autopsy Case of Progressive Supranuclear Palsy with Incidental
The Neuropathology Data Form
Identification of Genetic Modifiers in Hereditary Spastic Paraplegias Due to SPAST/SPG4 Mutations Livia Parodi
And Α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510val Mutation
Alzheimer Disease and Hereditary Spastic Paraplegia Hans Zempel1,3* and Eva-Maria Mandelkow1,2,3*
No Metagenomic Evidence of Causative Viral Pathogens in Postencephalitic Parkinsonism Following Encephalitis Lethargica
Novel Therapeutic Targets and Biomarkers for the Treatment Of
Tau Protein and Tauopathy (PDF)
Unclassified Four-Repeat Tauopathy Associated with Familial
Disease-Related Phenotypes in a Drosophila Model of Hereditary Spastic Paraplegia Are Ameliorated by Treatment with Vinblastine
Tau Pathology Found in Temporal Lobe Epilepsy
Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype
Progressive Supranuclear Palsy and Primary Lateral Sclerosis Secondary
Tauopathies with Parkinsonism: Clinical Spectrum, Neuropathologic Basis, Biological Markers, and Treatment Options
MAPT) and FTDP-17 (PGRN
Top View
Rare Forms of Dementia
Co-Morbidity of Progressive Supranuclear
The Role of White Matter Dysfunction and Leukoencephalopathy
Globular Glial Tauopathy Presenting As Semantic Variant Primary
Evolution of the Human Lifespan and Diseases of Aging: Roles of Infection, Inflammation, and Nutrition
The Significance of Tau Aggregates in the Human Brain
Genetic Epidemiology of Amyotrophic Lateral Sclerosis Genetische Epidemiologie Van Amyotrofische Lateraal Sclerose
Patient-Derived Stem Cell Models in SPAST HSP: Disease Modelling and Drug Discovery
Progressive Supranuclear Palsy:<Br>A Teaching Case Report
Designating Incurable Neurodegenerative Diseases
Alpha-Synuclein And
A Healthcare Provider's Guide To
Astrocytes in Neurodegenerative Diseases: a Perspective from Tauopathy and Α-Synucleinopathy
Clinical Approach to Progressive Supranuclear Palsy
Seizures Are a Druggable Mechanistic Link Between TBI and Subsequent Tauopathy
Seizures Are a Druggable Mechanistic Link Between TBI and Subsequent Tauopathy
Targeting Tauopathy with Engineered Tau-Degrading Intrabodies
The Pathogram of Alzheimer's Disease
Progressive Supranuclear Palsy New Concepts
Cellular and Regional Vulnerability in Frontotemporal Tauopathies
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
Combined FUS+ Basophilic Inclusion Body Disease and Atypical Tauopathy Presenting with an ALS/MND-Plus Phenotype
Clinical Diagnoses Among Individuals with Primary Age-Related Tauopathy Versus Alzheimer’S Neuropathology
Primary Age-Related Tauopathy and the Amyloid Cascade Hypothesis: the Exception That Proves the Rule? John F
Relevance of Mutations in Tau for Understanding the Tauopathies
Microtubule Dysfunction: a Common Feature of Neurodegenerative Diseases
Advances in Progressive Supranuclear Palsy: New Diagnostic Criteria, Biomarkers, and Therapeutic Approaches
Mutation Analysis of the Spastin Gene (SPG4) in Patients with Hereditary
Progressive Supranuclear Palsy
Researching Alzheimer's Medicines
Untangling the Tauopathy for Alzheimer's Disease and Parkinsonism
Neurodegeneration in Tauopathies and Synucleinopathies
Movement Disorders: a Practical Update
Hereditary Primary Lateral Sclerosis and Progressive Nonfluent Aphasia